The State of Infectious Diseases and New Trivalent Flu Vaccine ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore

Xtalks Life Science Podcast

In this episode, Ayesha spoke with William Schaffner, MD, Professor of Preventive Medicine Health Policy and Professor in the Division of Infectious Diseases at Vanderbilt University; and Kelly Moore, MD, MPH, President and CEO at Immunize.org and Associate Professor of Health Policy at Vanderbilt University.

Dr. Schaffner and Dr. Moore discussed the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation of a trivalent influenza vaccine strain selection, as opposed to a typical quadrivalent vaccine, with the 2024/2025 influenza season reflecting the removal of the B/Yamagata strain.

A renowned infectious disease expert, having appeared on numerous media outlets including CNN particularly during the COVID-19 pandemic, Dr. Schaffner’s primary interest has been the prevention of infectious diseases domestically and globally in both pediatric and adult populations. After residency training and a fellowship in infectious diseases at Vanderbilt University, Dr. Schaffner served in the US Public Health Service as an epidemic intelligence service officer with the Centers for Disease Control and Prevention (CDC) in Atlanta. After that tour of duty, Dr. Schaffner joined the faculty at Vanderbilt, establishing a long collaboration with the Tennessee Department of Health. Dr. Schaffner has been a member of numerous expert advisory committees that established national vaccine policy. Dr. Schaffner is also the current medical director and past president of the National Foundation for Infectious Diseases and has served on the executive board for the Infectious Diseases Society of America.

Prominent infectious disease expert Dr. Moore served for 14 years as the director of the Tennessee Immunization Program and later founded her own consulting company, The Vaccine Advisor, to advise public health and industry before her current role as president and CEO of immunize.org, a leading nonprofit organization focused on national and global vaccine policy and immunization program implementation. Dr. Moore has served in a variety of immunization policy advisory roles with the World Health Organization (WHO) since 2016, including as chair of its Immunization Practices Advisory Committee. Dr. Moore is a graduate of the Vanderbilt School of Medicine and the Harvard School of Public Health. She completed her public health leadership training as an epidemic intelligence service and preventive me